Amarin Corp Plc\Uk financial data

Symbol
AMRN on Nasdaq
Industry
Pharmaceutical Preparations
Location
Spaces South Docklands, Block C, 77 Sir John Rogerson's Quay, Dublin 2, Ireland
State of incorporation
United Kingdom
Fiscal year end
December 31
Former names
AMARIN PHARMACEUTICALS PLC (to 7/13/2000), ETHICAL HOLDINGS PLC (to 1/28/1998)
Latest financial report
10-K - Q4 2024 - Mar 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 315 % +15.8%
Quick Ratio 106 % +14%
Debt-to-equity 43 % -14.1%
Return On Equity -15.5 % -48.4%
Return On Assets -10.9 % -55.8%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 412M shares +0.68%
Entity Public Float 283M USD -41.7%
Common Stock, Value, Issued 305M USD +0.84%
Weighted Average Number of Shares Outstanding, Basic 411M shares +0.81%
Weighted Average Number of Shares Outstanding, Diluted 411M shares +0.81%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 229M USD -25.5%
Research and Development Expense 20.9M USD -6.08%
Operating Income (Loss) -91.8M USD -35.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -77.2M USD -43.8%
Income Tax Expense (Benefit) 4.98M USD -8.43%
Net Income (Loss) Attributable to Parent -82.2M USD -39%
Earnings Per Share, Basic -0.2 USD/shares -33.3%
Earnings Per Share, Diluted -0.2 USD/shares -33.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 121M USD -39.3%
Accounts Receivable, after Allowance for Credit Loss, Current 122M USD -8.45%
Inventory, Net 166M USD -35.8%
Assets, Current 595M USD -17.9%
Property, Plant and Equipment, Net 16K USD -86%
Operating Lease, Right-of-Use Asset 7.59M USD -8.64%
Other Assets, Noncurrent 1.21M USD -10.8%
Assets 685M USD -17.6%
Accounts Payable, Current 40.4M USD -23.5%
Employee-related Liabilities, Current 15.4M USD -18.9%
Contract with Customer, Liability, Current 2.34M USD +6.46%
Liabilities, Current 180M USD -30.6%
Contract with Customer, Liability, Noncurrent 2.11M USD -83.4%
Operating Lease, Liability, Noncurrent 7.72M USD -11.6%
Other Liabilities, Noncurrent 11.5M USD +26.9%
Liabilities 199M USD -28.8%
Retained Earnings (Accumulated Deficit) -1.67B USD -5.18%
Stockholders' Equity Attributable to Parent 486M USD -11.9%
Liabilities and Equity 685M USD -17.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.6M USD -79.8%
Net Cash Provided by (Used in) Financing Activities -1.43M USD -492%
Net Cash Provided by (Used in) Investing Activities 28.7M USD
Common Stock, Shares, Issued 422M shares +0.98%
Common Stock, Par or Stated Value Per Share 0.5 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 14.7M USD
Deferred Tax Assets, Valuation Allowance 188M USD +9.18%
Deferred Tax Assets, Gross 192M USD +8.85%
Operating Lease, Liability 9.7M USD -8.49%
Lessee, Operating Lease, Liability, to be Paid 12.7M USD -13.2%
Property, Plant and Equipment, Gross 1.49M USD -0.47%
Operating Lease, Liability, Current 1.95M USD +4.33%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.56M USD +29.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.94M USD -0.84%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.05M USD -24.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.97M USD -14.3%
Deferred Tax Assets, Operating Loss Carryforwards 166M USD +8%
Unrecognized Tax Benefits 19.5M USD +4.42%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.98M USD -9.31%
Additional Paid in Capital 1.91B USD +0.81%
Amortization of Intangible Assets 729K USD +3.85%
Deferred Tax Assets, Net of Valuation Allowance 4.36M USD -3.5%